CA2867638A1 - Biorelevant compositions - Google Patents

Biorelevant compositions Download PDF

Info

Publication number
CA2867638A1
CA2867638A1 CA2867638A CA2867638A CA2867638A1 CA 2867638 A1 CA2867638 A1 CA 2867638A1 CA 2867638 A CA2867638 A CA 2867638A CA 2867638 A CA2867638 A CA 2867638A CA 2867638 A1 CA2867638 A1 CA 2867638A1
Authority
CA
Canada
Prior art keywords
sodium
biorelevant
mole
surfactants
aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2867638A
Other languages
English (en)
French (fr)
Inventor
Mathew Louis Steven Leigh
Steve Leigh
Jennifer Dressman
Bastian KLOEFER
Marcel ARNDT
Alexander Fuchs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biorelevant Com Ltd
Original Assignee
Phares Pharmaceutical Research NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phares Pharmaceutical Research NV filed Critical Phares Pharmaceutical Research NV
Publication of CA2867638A1 publication Critical patent/CA2867638A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
    • G09B23/30—Anatomical models
    • G09B23/303—Anatomical models specially adapted to simulate circulation of bodily fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
    • G09B23/30—Anatomical models
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Computational Mathematics (AREA)
  • Educational Administration (AREA)
  • Mathematical Analysis (AREA)
  • Business, Economics & Management (AREA)
  • Algebra (AREA)
  • Pure & Applied Mathematics (AREA)
  • Mathematical Optimization (AREA)
  • Mathematical Physics (AREA)
  • Educational Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Fodder In General (AREA)
CA2867638A 2012-03-30 2013-04-02 Biorelevant compositions Abandoned CA2867638A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12162548.7A EP2645099A1 (en) 2012-03-30 2012-03-30 Biorelevant compositions
EP12162548.7 2012-03-30
PCT/EP2013/056945 WO2013144374A1 (en) 2012-03-30 2013-04-02 Biorelevant compositions

Publications (1)

Publication Number Publication Date
CA2867638A1 true CA2867638A1 (en) 2013-10-03

Family

ID=48143258

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2867638A Abandoned CA2867638A1 (en) 2012-03-30 2013-04-02 Biorelevant compositions

Country Status (11)

Country Link
US (1) US20150064794A1 (https=)
EP (2) EP2645099A1 (https=)
JP (1) JP6348480B2 (https=)
KR (1) KR20140144255A (https=)
CN (1) CN104582689A (https=)
BR (1) BR112014024256A8 (https=)
CA (1) CA2867638A1 (https=)
IN (1) IN2014DN07927A (https=)
MX (1) MX357927B (https=)
NZ (1) NZ700064A (https=)
WO (1) WO2013144374A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102034606B1 (ko) * 2011-08-23 2019-10-22 알레간 세일즈, 엘엘씨 데옥시콜린산 및 그의 염들의 제형물들
WO2019199238A1 (en) * 2018-04-09 2019-10-17 Vet Products Research And Innovation Center Company Limited Inorganic mineral entrapped in nanoparticle production method thereof
GB201809627D0 (en) * 2018-06-12 2018-07-25 Biorelevant Com Ltd Methods for preparing buffer solutions suitable for in vitro drug dissolution testing, drug solubility testing and/or drug profiling
GB201904757D0 (en) * 2019-04-04 2019-05-22 Biorelevant Com Ltd Biorelevant composition
CN114080539A (zh) * 2019-06-28 2022-02-22 詹森药业有限公司 生物相关溶出介质
WO2021165386A1 (de) 2020-02-19 2021-08-26 Bayer Aktiengesellschaft Vorhersage von formulierungseigenschaften
GB202112975D0 (en) 2021-09-10 2021-10-27 Biorelevant Com Ltd Biorelevant dissolution compositions with reproducible spectral profiles
GB202405714D0 (en) * 2024-04-23 2024-06-05 Biorelevant Com Ltd Biorelevant compositions and media for in vitro testing

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
GB8909022D0 (en) * 1989-04-20 1989-06-07 Cortecs Ltd Pharmaceutical compositions
US6040188A (en) * 1997-11-18 2000-03-21 The Regents Of The University Of California In vitro gastrointestinal mimetic protocol for measuring bioavailable contaminants
IT1296914B1 (it) * 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
WO2003042392A1 (en) * 2001-11-15 2003-05-22 Phares Pharmaceutical Research N.V. Standardised phospholipid mixtures
CA2560900A1 (en) * 2004-03-26 2005-10-06 Cell Therapeutics Europe S.R.L. Nanoparticle formulations of platinum compounds
GB0522942D0 (en) * 2005-11-10 2005-12-21 Leigh Steven Dissolution composition
WO2007085970A2 (en) * 2006-01-27 2007-08-02 Danisco A/S Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders
WO2008040799A2 (en) 2006-10-06 2008-04-10 Boehringer Ingelheim International Gmbh Process for preparing instant forms of aqueous mixed micellar solutions as physiological buffer systems for use in the analysis of in vitro release

Also Published As

Publication number Publication date
NZ700064A (en) 2016-08-26
BR112014024256A2 (https=) 2017-06-20
IN2014DN07927A (https=) 2015-05-01
BR112014024256A8 (pt) 2018-02-06
EP2645099A1 (en) 2013-10-02
US20150064794A1 (en) 2015-03-05
MX2014011789A (es) 2015-06-03
JP2015524913A (ja) 2015-08-27
MX357927B (es) 2018-07-27
WO2013144374A1 (en) 2013-10-03
CN104582689A (zh) 2015-04-29
JP6348480B2 (ja) 2018-06-27
EP2830592A1 (en) 2015-02-04
KR20140144255A (ko) 2014-12-18

Similar Documents

Publication Publication Date Title
CA2867638A1 (en) Biorelevant compositions
Warren et al. Real time evolution of liquid crystalline nanostructure during the digestion of formulation lipids using synchrotron small-angle X-ray scattering
Shaikh et al. Interaction of cholesterol with a docosahexaenoic acid-containing phosphatidylethanolamine: trigger for microdomain/raft formation?
US8889189B2 (en) Dissolution composition for examining drug solubility
McPherson et al. Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid
Diao et al. In vitro digestion of emulsified lard‐based diacylglycerols
Shen et al. The digestion and absorption characteristics of human milk phospholipid analogs: a combination study between in vitro and in vivo
US20220178900A1 (en) Biorelevant composition
RU2848693C1 (ru) Порошок для приготовления биорелевантных сред, имитирующих состав отделов желудочно-кишечного тракта человека
Goovaerts et al. Exploring Digestion-Induced Fed-State Simulated Intestinal Media with a Lipid Fraction and Compositional Variability
Zhou Novel experimental techniques for biopharmaceutical analysis
US20220373446A1 (en) Biorelevant dissolution media
CN102662038A (zh) 评价低溶解度化合物吸收特性的方法
JP2005538680A (ja) リン脂質転移蛋白質（ｐｌｔｐ）活性の測定
Phan Nanostructure formation during lipid digestion
AU2013203788A1 (en) Dissolution composition for examining drug solubility

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180320

FZDE Discontinued

Effective date: 20200831